Also trades as: RPHCF (OTC) · $vol 0M
4527.T JPX
Rohto Pharmaceutical Co.,Ltd.
1W: -0.3%
1M: -8.7%
3M: +16.8%
YTD: +8.0%
1Y: +13.1%
3Y: -4.3%
5Y: +93.7%
¥2,788.00 ($17.67)
-32.00 (-1.13%)
Weekly Expected Move ±3.2%
¥2609
¥2699
¥2788
¥2877
¥2967
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$47.8B
+29.4% ▲
5Y CAGR: +19.0%
Capital Expenditures
$11.5B
-26.6% ▼
5Y CAGR: +2.2%
Free Cash Flow
$36.3B
+30.4% ▲
5Y CAGR: +30.2%
Dividends Paid
$9.3B
-31.0% ▼
Buybacks
$0
+100.0% ▲
Net Change in Cash
$13.6B
+201.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $28.0B | $34.3B | $30.9B | $31.0B | $34.2B |
| Depreciation & Amort. | $7.7B | $7.8B | $8.7B | $13.1B | $17.4B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $458M | -$11.3B | -$8.9B | -$6.0B | -$5.7B |
| Other Non-Cash Items | -$8.8B | $110M | $3.5B | -$1.2B | $1.9B |
| Operating Cash Flow | $27.2B | $30.9B | $34.2B | $36.9B | $47.8B |
| — Investing Activities — | |||||
| Capital Expenditures | -$11.3B | -$9.9B | -$8.0B | -$10.6B | -$26.3B |
| Acquisitions (Net) | -$1.2B | -$1.6B | $0 | -$42.8B | $26M |
| Investment Purchases | -$5.6B | -$5.9B | -$9.1B | -$9.5B | -$7.3B |
| Investment Sales | $2.0B | $2.6B | $1.7B | $6.0B | $4.0B |
| Other Investing | -$223M | $1.6B | -$962M | -$593M | -$273M |
| Investing Cash Flow | -$16.4B | -$13.2B | -$16.3B | -$57.5B | -$29.8B |
| — Financing Activities — | |||||
| Net Debt Issuance | $7.6B | -$9.9B | -$1.2B | $31.9B | -$2.6B |
| Stock Repurchased | $0 | $0 | $0 | -$5.0B | $0 |
| Dividends Paid | -$3.4B | -$4.7B | -$5.5B | -$7.1B | -$9.3B |
| Other Financing | -$698M | -$1.6B | -$7.1B | -$16.1B | -$3M |
| Financing Cash Flow | $3.5B | -$16.2B | -$13.8B | $3.7B | -$11.8B |
| Net Change in Cash | $18.7B | $6.8B | $8.9B | -$13.3B | $13.6B |
| Cash End of Period | $70.9B | $77.7B | $86.6B | $73.2B | $86.8B |
| Free Cash Flow | $15.9B | $21.0B | $25.3B | $27.8B | $36.3B |